Abstract:The excessive production of various reactive oxidant species over endogenous antioxidant defense mechanisms leads to the development of a state of oxidative stress, with serious biological consequences. The consequences of oxidative stress depend on the balance between the generation of reactive oxidant species and the antioxidant defense and include oxidative damage of biomolecules, disruption of signal transduction, mutation, and cell apoptosis. Accumulating evidence suggests that oxidative stress is involved in the physiopathology of various debilitating illnesses associated with chronic inflammation, including cardiovascular diseases, diabetes, cancer, or neurodegenerative processes, that need continuous pharmacological treatment. Oxidative stress and chronic inflammation are tightly linked pathophysiological processes, one of which can be simply promoted by another. Although, many antioxidant trials have been unsuccessful (some of the trials showed either no effect or even harmful effects) in human patients as a preventive or curative measure, targeting oxidative stress remains an interesting therapeutic approach for the development of new agents to design novel anti-inflammatory drugs with a reliable safety profile. In this regard, several natural antioxidant compounds were explored as potential therapeutic options for the treatment of chronic inflammatory diseases. Several metalloenzymes, such as superoxide dismutase, catalase, and glutathione peroxidase, are among the essential enzymes that maintain the low nanomolar physiological concentrations of superoxide (O 2 •−) and hydrogen peroxide (H 2 O 2 ), the major redox signaling molecules, and thus play important roles in the alteration of the redox homeostasis. These enzymes have become a striking source of motivation to design catalytic drugs to enhance the action of these enzymes under pathological conditions related to chronic inflammation. This review is focused on several major representatives of natural and synthetic antioxidants as potential drug candidates for the treatment of chronic inflammatory diseases.

Therapies with Antioxidant Potential in Psoriasis, Vitiligo, and Lichen Planus

Oxidative Imbalance in Psoriasis with an Emphasis on Psoriatic Arthritis: Therapeutic Antioxidant Targets

Unraveling Mitochondrial Reactive Oxygen Species Involvement in Psoriasis: The Promise of Antioxidant Therapies

Possible Role of Nutraceuticals as an Additional Therapeutic Strategy

Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review

Oxidative Stress and Phototherapy in Atopic Dermatitis: Mechanisms, Role, and Future Perspectives

Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches

Oxidative Stress in the Pathogenesis of Psoriasis

Antioxidant mechanisms of mesenchymal stem cells and their therapeutic potential in vitiligo

The Impact of Antioxidants on Vitiligo and Melasma: A Scoping Review and Meta-Analysis

Vitamin D, omega-3 polyunsaturated fatty acids, antioxidants in the treatment of psoriasis

The Current Status of Antioxidants in the Treatment of Vitiligo in China.

Research Progress on Targeted Antioxidant Therapy and Vitiligo

The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications

Potential use of antioxidants for the treatment of chronic inflammatory diseases

Oxidative Stress as an Important Contributor to the Pathogenesis of Psoriasis

Effects of Different Therapeutic Approaches on Redox Balance in Psoriatic Patients

Evaluation of Advanced Oxidation Protein Products, Prooxidant-Antioxidant Balance, and Total Antioxidant Capacity in Untreated Vitiligo Patients

The Role of Lifestyle and Nutrition in Psoriasis: Current Status of Knowledge and Interventions

Role of reactive oxygen species and antioxidants in atopic dermatitis

The Involvement of Oxidative Stress in Psoriasis: A Systematic Review